SUSAN BLANEY to Pediatrics
This is a "connection" page, showing publications SUSAN BLANEY has written about Pediatrics.
Connection Strength
0.779
-
Editorial: Recent advances in pediatric oncology. Curr Opin Pediatr. 2019 02; 31(1):1-2.
Score: 0.330
-
Recent advances in pediatric oncology. Curr Opin Pediatr. 2018 02; 30(1):1-2.
Score: 0.308
-
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group. Eur J Cancer. 2012 Mar; 48(4):579-85.
Score: 0.050
-
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 15; 13(6):1789-93.
Score: 0.036
-
New approaches to drug development in pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):324-30.
Score: 0.032
-
Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics. 2011 Mar; 11(5):935-43.
Score: 0.012
-
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 01; 29(7):839-44.
Score: 0.012